Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

India Globalization Capital, Inc. (NYSE: IGC) Could Release Potential Blockbuster Alzheimer’s Treatment in Early 2018

On the verge of releasing potential Cannabis-based blockbuster Alzheimer’s treatment Company is able to hugely accelerate release of this treatment in recreational cannabis states Market potential for drugs to treat and prevent Alzheimer’s is in the billions of dollars According to information from the Alzheimer’s Association, approximately 47 million people are living with dementia throughout […]

$230 Million ICO on the Rocks

A recent Reuters special report on an imperiled cryptocurrency venture shines a harsh light on some of the many risks and the paucity of regulatory oversight in cryptocurrencies and Initial Coin Offerings (ICOs) (http://dtn.fm/Jvc7A). Cryptocurrencies are digital mediums of exchange that function through extremely complex code systems called blockchain technology that encrypt sensitive data transfers, […]

Grey Cloak Tech Inc. (GRCK) is “One to Watch”

Eqova Life Sciences subsidiary serves underserved market in booming CBD sector Clinical-grade, full-spectrum hemp oil products specifically produced for licensed medical use CBD market expected to grow 700% to $2.1 billion by 2020 Grey Cloak Tech Inc. (OTCQB: GRCK), a Las Vegas, Nevada-based company, targets the rapidly growing cannabinoid (CBD) market through its wholly owned […]

Recent News Highlights the Growing Market for Patriot One Technologies, Inc.’s (TSX.V: PAT) (OTCQB: PTOTF) High Technology Device

Company’s PATSCAN™ Cognitive Microwave Radar (CMR) detects concealed weapons and identifies new threats Report: Airport security market $9 billion in 2016, projected compound annual growth rate (CAGR) of 7%, 2016–2024 Martin Cronin, CEO, calls technology “game changing” in deterring violence before it happens Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) offers technology that can […]

Skinvisible, Inc. (SKVI) Targets Global Skincare Market Projected to Reach $135B by 2021

Owns patented Invisicare® polymer delivery system, prescription and over-the-counter skincare products formulated with Invisicare Business model to grow globally by out-licensing its proprietary and patented product line Developed multiple cannabis-based products with CBD from imported hemp (non-psychoactive), and will continue to develop line utilizing CBD and THC from marijuana Skinvisible, Inc. (OTCQB: SKVI) is targeting […]

Liberty Leaf Holdings Ltd. (OTCQB: LIBFF) (CSE: LIB) (FSE: HN3P) Subsidiary Plans to Boost Storage Capacity

In new business plan sent to Health Canada, subsidiary North Road Ventures proposes doubling its cannabis product lines, adding oil products (CBD) and boosting by five-fold its storage capacity Statista report projects Canadian marijuana market will reach C$2.8 billion by 2020 Company sees cannabis oil products accounting for 50% or more of projected sales Liberty […]

Cache Elite, Inc. (ILUS) Takes Travel into the Future with TripWitz

TripWitz platform is an OTA offering the expertise of actual travel agents Serves hundreds of high-demand destinations around the globe Accepts bitcoin payments There has never been a smarter way to plan for a vacation than with TripWitz from Cache Elite, Inc. (OTC: ILUS). TripWitz lets tech-savvy Millennials choose their holiday destinations, accommodation, tour packages […]

 

From Our Blog

Improving the Odds: How LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Is Working to Make Cancer Therapies More Effective

February 4, 2026

Despite decades of progress in oncology, many cancers remain resistant to treatment, not because therapies are unavailable, but because tumor cells adapt. Immunotherapies and chemotherapies can produce meaningful responses, yet durability and consistency remain challenges, particularly in aggressive or rare cancer subtypes. Increasingly, research is shifting toward approaches that improve how well existing treatments work, […]

Rotate your device 90° to view site.